Home › Malattia di Crohn › Washington › Tacoma
Studi clinici su Malattia di Crohn a Tacoma, WA
11 studi su Malattia di Crohn cercano partecipanti presso sedi a Tacoma e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
In reclutamentoFase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
In reclutamentoFase 3
- Washington Gastroenterology - Tacoma ( Site 5004), Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
In reclutamentoFase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
In reclutamentoFase 2
- Washington Gastroenterology - Tacoma /ID# 267302, Tacoma
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 2/3
- GI Alliance Tacoma, Tacoma
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
In reclutamentoFase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
In reclutamentoFase 4
- Washington Gastroenterology- GIA, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- GI Alliance Tacoma, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
In reclutamentoFase 3
- MultiCare Institute for Research & Innovation, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
In reclutamentoFase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
In reclutamentoFase 2
- Mirador Therapeutics Selected Site, Tacoma
Studi su Malattia di Crohn in altre città
- New York City, NY35 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Orlando, FL17 studi
- Houston, TX17 studi
- Atlanta, GA17 studi
- Tyler, TX16 studi
- San Diego, CA15 studi
- San Antonio, TX15 studi
- Los Angeles, CA15 studi
Altri studi a Tacoma
- Cancro del polmone non a piccole cellule20 studi
- Cancro al seno18 studi
- Colite ulcerosa15 studi
- Mieloma multiplo13 studi
- Cancro alla prostata11 studi
- Cancro metastatico9 studi
- Cancro colorettale9 studi
- Melanoma7 studi
- Cancro ovarico7 studi
- Cancro (tutti i tipi)6 studi
- Cancro pancreatico6 studi
- Obesità6 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.